Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.362 USD | -2.16% | +3.02% | -71.50% |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 3.2M |
---|---|---|---|---|---|
Net income 2021 | -14M | Net income 2022 | -15M | EV / Sales 2021 | - |
Net cash position 2021 | 4.62M | Net cash position 2022 | 9.65M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.32
x | P/E ratio 2022 |
-0.21
x | Employees | 4 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 60.25% |
Latest transcript on CNS Pharmaceuticals, Inc.
1 day | -2.16% | ||
1 week | +3.02% | ||
Current month | +30.22% | ||
1 month | +38.75% | ||
3 months | -71.27% | ||
6 months | -67.09% | ||
Current year | -71.50% |
Managers | Title | Age | Since |
---|---|---|---|
John Climaco
CEO | Chief Executive Officer | 55 | 17-08-31 |
Director of Finance/CFO | 45 | 19-11-12 | |
Sandra Silberman
CTO | Chief Tech/Sci/R&D Officer | 69 | 17-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Picker
CTO | Chief Tech/Sci/R&D Officer | 78 | 17-12-31 |
John Climaco
CEO | Chief Executive Officer | 55 | 17-08-31 |
Faith Charles
CHM | Chairman | 62 | 23-01-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.362 | -2.16% | 182,004 |
24-03-27 | 0.37 | -1.33% | 130,851 |
24-03-26 | 0.375 | -0.79% | 27,126 |
24-03-25 | 0.378 | 0.00% | 116,820 |
24-03-22 | 0.378 | +7.57% | 78,188 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-71.50% | 2.25M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |